CYT003, a TLR9 agonist, in persistent allergic asthma - a randomized placebo-controlled Phase 2b study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CYT003, a TLR9 agonist, in persistent allergic asthma - a randomized placebo-controlled Phase 2b study

Published:2015-06-22 Issue:9 Volume:70 Page:1160-1168
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Casale T. B.¹,Cole J.²,Beck E.³,Vogelmeier C. F.⁴,Willers J.⁵,Lassen C.⁵,Hammann-Haenni A.⁵,Trokan L.⁵,Saudan P.⁵,Wechsler M. E.⁶

Affiliation:

1. Department of Internal Medicine; University of South Florida; Tampa FL USA

2. IPS Research Company; Oklahoma City OK USA

3. Medical Department; Institut fuer Gesundheitsfoerderung; Ruedersdorf Brandenburg Germany

4. Department of Pneumology; University of Marburg; Marburg Germany

5. Cytos Biotechnology AG; Schlieren Switzerland

6. Department of Medicine; National Jewish Health; Denver CO USA

Funder

Cytos

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. GINA Report Global strategy for asthma management and prevention http://www.ginasthma.org/ReportItem.asp?l152&l252&intId594

2. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma;Sullivan;Allergy,2007

3. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study;Bateman;Am J Respir Crit Care Med,2004

4. Nonadherence in asthmatic patients: is there a solution to the problem?;Bender;Ann Allergy Asthma Immunol,1997

5. Asthma and adherence to inhaled corticosteroids: current status and future perspectives;Bårnes;Respir Care,2015

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation;Cells;2023-09-05

2. The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis;Frontiers in Immunology;2023-04-11

3. Allergen immunotherapy: past, present and future;Nature Reviews Immunology;2022-10-17

4. Pathogen Recognition Receptors and the Lung;Encyclopedia of Respiratory Medicine;2022

5. Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act;Chemical Reviews;2021-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3